I. Houri

发表

Emergency department targeted screening for hepatitis C does not improve linkage to care

O. Shibolet, N. Horowitz, H. Katchman, 2020, World journal of gastroenterology.

± Ribavirin following protease inhibitors failure - A Prospective Multi-Centre Trial CURRENT STATUS: REVIEW

I. Houri, L. Deutsch, 2020 .

Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial

O. Mor, O. Shibolet, R. Bruck, 2019, BMC Infectious Diseases.

Metabolic Regulation of SARS-CoV-2 Infection

Matan Hofree, C. Sirtori, Y. Nahmias, 2021 .

Liposomal amphotericin B (Ambisome) is safe and effective in the treatment of invasive mycosis in organ transplant patients.

R. Nakache, I. Houri, R. Orni-Wasserlauf, 2001, Transplantation proceedings.

Real-World Management of Patients with Primary Biliary Cholangitis—A Retrospective Study from a Tertiary Medical Center in Israel

M. Leshno, O. Shibolet, E. Zigmond, 2021, Journal of clinical medicine.

Hepatocellular Carcinoma Associated with Hepatitis B Virus

O. Shibolet, I. Houri, 2016 .

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

D. Schwartz, D. Turner, O. Shibolet, 2021, American Journal of Transplantation.

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

D. Turner, O. Shibolet, L. Rabinowich, 2021, Journal of Hepatology.

Repetitive amiodarone administration causes liver damage via adipose tissue ER-stress dependent lipolysis, leading to hepatotoxic free fatty acid accumulation.

S. Fishman, O. Shibolet, R. Käkelä, 2021, American journal of physiology. Gastrointestinal and liver physiology.

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study

Matan Hofree, C. Sirtori, Y. Nahmias, 2023, eLife.

Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine

D. Schwartz, D. Turner, O. Shibolet, 2021, Clinical transplantation.

Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients

D. Schwartz, D. Hagin, D. Turner, 2022, Transplantation Proceedings.

Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus

O. Mor, D. Turner, O. Shibolet, 2022, International journal of environmental research and public health.

Prognostic Scores for Ursodeoxycholic Acid-Treated Patients Predict Graft Loss and Mortality in Recurrent Primary Biliary Cholangitis after Liver Transplantation.

A. Floreani, P. Trivedi, C. Corpechot, 2024, Journal of hepatology.

Primary Biliary Cholangitis: Pathophysiology.

G. Hirschfield, I. Houri, Inbal Houri, 2023, Clinics in liver disease.